KR100538652B1 - 항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 - Google Patents
항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 Download PDFInfo
- Publication number
- KR100538652B1 KR100538652B1 KR10-2003-0052321A KR20030052321A KR100538652B1 KR 100538652 B1 KR100538652 B1 KR 100538652B1 KR 20030052321 A KR20030052321 A KR 20030052321A KR 100538652 B1 KR100538652 B1 KR 100538652B1
- Authority
- KR
- South Korea
- Prior art keywords
- rice
- extract
- weight
- coating
- functional
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 99
- 235000009566 rice Nutrition 0.000 title claims abstract description 99
- 239000011248 coating agent Substances 0.000 title claims abstract description 31
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 241000209094 Oryza Species 0.000 title abstract 8
- 239000012676 herbal extract Substances 0.000 claims abstract description 31
- 238000000576 coating method Methods 0.000 claims abstract description 27
- 240000007594 Oryza sativa Species 0.000 claims description 91
- 239000000284 extract Substances 0.000 claims description 53
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 19
- 240000000599 Lentinula edodes Species 0.000 claims description 8
- 235000014066 European mistletoe Nutrition 0.000 claims description 5
- 235000015468 Lycium chinense Nutrition 0.000 claims description 5
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 5
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 5
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 229910000898 sterling silver Inorganic materials 0.000 claims description 2
- 239000010934 sterling silver Substances 0.000 claims description 2
- 241000272814 Anser sp. Species 0.000 claims 1
- 244000241838 Lycium barbarum Species 0.000 claims 1
- 244000152640 Rhipsalis cassutha Species 0.000 claims 1
- 239000008199 coating composition Substances 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 47
- 206010028980 Neoplasm Diseases 0.000 description 25
- 201000011510 cancer Diseases 0.000 description 16
- 238000012360 testing method Methods 0.000 description 13
- 230000004083 survival effect Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 208000006268 Sarcoma 180 Diseases 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000007758 minimum essential medium Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 244000241872 Lycium chinense Species 0.000 description 4
- 241000221012 Viscum Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- 241000123107 Phellinus Species 0.000 description 3
- 244000305267 Quercus macrolepis Species 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 240000001659 Oldenlandia diffusa Species 0.000 description 2
- 241000722281 Saururus Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000222355 Trametes versicolor Species 0.000 description 2
- 241000001727 Tropicoporus linteus Species 0.000 description 2
- 241000221013 Viscum album Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004712 cancer cell adhesion Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- DBGSRZSKGVSXRK-UHFFFAOYSA-N 1-[2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]acetyl]-3,6-dihydro-2H-pyridine-4-carboxylic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CCC(=CC1)C(=O)O DBGSRZSKGVSXRK-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 240000008444 Celtis occidentalis Species 0.000 description 1
- 235000018962 Celtis occidentalis Nutrition 0.000 description 1
- 108091005960 Citrine Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000123110 Fuscoporia gilva Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000123392 Hymenochaetaceae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241001570521 Lonicera periclymenum Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 241000123113 Phellinus igniarius Species 0.000 description 1
- 239000008681 Phellinus linteus extract Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 201000007455 central nervous system cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011035 citrine Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000012826 global research Methods 0.000 description 1
- 235000020687 goji berry extract Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 231100000338 sulforhodamine B assay Toxicity 0.000 description 1
- 238000003210 sulforhodamine B staining Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001875 tumorinhibitory effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
실시예 1의 생약 추출물(20.1 brix) | 실시예 2의 생약 추출물(26.5 brix) | 물 및 가용성 전분(㎖) | 쌀(완전미, g) | ||||
5 중량% | 10 중량% | 15 중량% | 10 중량% | 15 중량% | |||
실시예 3 | 7.5㎖ | - | - | - | - | 7.5 | 300 |
실시에 4 | - | 15 | - | - | - | 7.5 | 300 |
실시예 5 | - | - | 22.5 | - | - | 7.5 | 300 |
실시예 6 | - | - | - | 15 | - | 7.5 | 300 |
실시예 7 | - | - | - | - | 30 | 7.5 | 300 |
dose(mg/kg) | 투여경로 | MST(평균생존일수, day) | ILS(%, 생존일수연장율) | 30 days survivors(30일간 생존수) | |
대조군 | saline | p.o(경구) | 19.5 | - | 0/10 |
실시예 1 | 150 | p.o(경구) | 29.3 | 150 이상 | 5/10 |
실시예 2 | 200 | p.o(경구) | 26.3 | 135 이상 | 3/10 |
dose(mg/kg) | 투여경로 | Tumor weight(종양무게, g) | Inhibition(저해율, %) | |
대조군 | saline | p.o(경구) | 1.70±0.25 | - |
실시예 1 | 150 | p.o(경구) | 0.50±0.25 | 70.4 |
실시예 2 | 200 | p.o(경구) | 0.77±0.21 | 54.8 |
농도(㎍/㎖) | 시료 | cell | ||||
A549(폐암세포주) | SK-OV-3(난암세포주) | SK-MEL-2(색소세포암) | XF498(중추신경세포암) | HTC15(결장세포) | ||
6.25 | 실시예 1 | 101.2 | 104.2 | 106.7 | 105.2 | 104.5 |
실시예 2 | 100.4 | 101.5 | 105.2 | 103.4 | 102.9 | |
12.5 | 실시예 1 | 100.5 | 103.8 | 105.8 | 105.9 | 105.2 |
실시예 2 | 101.2 | 100.5 | 104.1 | 104.2 | 101.7 | |
25.0 | 실시예 1 | 101.7 | 93.77 | 104.2 | 104.2 | 106.7 |
실시예 2 | 100.5 | 91.44 | 99.7 | 102.1 | 101.8 | |
50.0 | 실시예 1 | 102.3 | 101.4 | 101.6 | 100.5 | 103.2 |
실시예 2 | 99.8 | 98.4 | 100.2 | 100.7 | 101.2 | |
100.0 | 실시예 1 | 100.7 | 99.7 | 99.4 | 99.8 | 100.6 |
실시예 2 | 99.2 | 97.5 | 99.6 | 99.2 | 100.6 | |
200.0 | 실시예 1 | 99.8 | 98.2 | 98.5 | 99.1 | 100.2 |
실시예 2 | 95.5 | 95.4 | 97.7 | 98.3 | 99.8 |
농도(㎎/㎖) | 상대흡광도(570nm) |
대조구 | 1.00 |
0.125 | 0.74 |
0.250 | 0.25 |
0.500 | 0.03 |
1.000 | 0.00 |
2.000 | 0.00 |
정상립 | 분상립 | 절립 | 피해립 | 동활 | |
코팅전(일반쌀) | 186 | 11 | 114 | 64 | 125 |
실시예 3 | 244 | 2 | 56 | 70 | 128 |
실시예 4 | 171 | 3 | 50 | 175 | 101 |
실시예 5 | 105 | 3 | 62 | 267 | 63 |
실시예 6 | 139 | 4 | 74 | 175 | 108 |
실시예 7 | 77 | 5 | 46 | 336 | 36 |
길이(mm) | 폭(mm) | 두께(mm) | 1개당 무게(g) | 10g 당 쌀알수 | |
일반쌀 | 4.875 | 2.738 | 1.931 | 0.0194 | 515 |
실시예 3 | 5.003 | 2.818 | 2.019 | 0.0196 | 510 |
실시예 4 | 5.081 | 2.880 | 2.073 | 0.0198 | 505 |
실시예 6 | 5.006 | 2.800 | 1.994 | 0.0195 | 513 |
실시예 7 | 5.015 | 2.893 | 2.001 | 0.0196 | 510 |
수분 | 조지방 | 조단백질 | 조회분 | 탄수화물 | 단백다당체 (mg%) | |
일반쌀 | 12.5 | 0.40 | 7.92 | 0.63 | 78.55 | - |
실시예 3 | 12.9 | 0.39 | 7.81 | 0.62 | 78.28 | 385 |
실시예 4 | 13.1 | 0.37 | 7.65 | 0.61 | 78.27 | 764 |
실시예 6 | 12.8 | 0.39 | 7.84 | 0.62 | 78.35 | 35 |
실시예 7 | 12.9 | 0.38 | 7.73 | 0.61 | 78.38 | 43 |
관능적 특성 | 실시예 3 | 실시예 4 | 실시예 5 | 실시예 6 | 실시예 7 | 비교예 1 |
향 | ++ | +++ | ++ | +++ | +++ | + |
외관 | ++ | ++ | ++ | ++ | +++ | + |
조직감 | ++ | ++ | +++ | ++ | ++ | + |
맛 | +++ | +++ | ++ | +++ | ++ | + |
종합적 기호도 | +++ | +++ | +++ | +++ | +++ | + |
Claims (4)
- 상황버섯 추출물 6 내지 9 중량%;, 운지버섯 추출물 6 내지 9 중량%;, 표고버섯 추출물 6 내지 9 중량%, 느타리버섯 추출물 6 내지 9 중량%, 황정 추출물 30 내지 35 중량%, 백화사설초 추출물 2 내지 5 중량%, 겨우살이 추출물 2 내지 4 중량%, 삼백초 추출물 2 내지 5 중량%, 금은화 추출물 2 내지 5 중량%, 구기자 추출물 2 내지 5 중량%, 지치 추출물 2 내지 5 중량%를 포함하는 것을 특징으로 하는 항암효과가 있는 쌀 코팅용 생약 추출물 조성물.
- 제1항의 쌀 코팅용 생약 추출물 조성물로 코팅된 기능성 쌀.
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0052321A KR100538652B1 (ko) | 2003-07-29 | 2003-07-29 | 항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0052321A KR100538652B1 (ko) | 2003-07-29 | 2003-07-29 | 항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050013766A KR20050013766A (ko) | 2005-02-05 |
KR100538652B1 true KR100538652B1 (ko) | 2005-12-26 |
Family
ID=37225086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-0052321A KR100538652B1 (ko) | 2003-07-29 | 2003-07-29 | 항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100538652B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100810843B1 (ko) * | 2006-07-28 | 2008-03-06 | 정광호 | 기능성 곡물 및 그 제조방법 |
KR101897029B1 (ko) * | 2016-03-03 | 2018-10-18 | 이부활 | 영양강화 쌀눈식품의 제조방법 |
-
2003
- 2003-07-29 KR KR10-2003-0052321A patent/KR100538652B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20050013766A (ko) | 2005-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Islam et al. | Bio-active compounds of bitter melon genotypes (Momordica charantia L.) in relation to their physiological functions | |
CN101023802A (zh) | 全营养绿色保健粉(丝、条)和方便(速食)粉(丝、条)系列产品及其制作方法 | |
KR101062172B1 (ko) | 버섯 발효인삼 분말을 함유하는 항암용 건강식품 | |
KR20150085566A (ko) | 항고혈압 저염 간장의 제조방법 | |
Jones | Maitake: a potent medicinal food | |
KR100538652B1 (ko) | 항암효과가 있는 쌀 코팅용 생약 추출물 조성물 및 이러한 조성물로 코팅된 기능성 쌀 | |
KR102254420B1 (ko) | 약용 및 식용 천연물 복합 발효액을 유효성분으로 함유하는 항균 조성물 | |
KR100699782B1 (ko) | 댕댕이나무 추출물을 포함하는 간 기능 회복용 식품 조성물 | |
KR102115622B1 (ko) | 약용 및 식용 천연물 복합 발효액을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 | |
Negi et al. | Evaluation of antihypertensive effect of fruit beverage of Crataegus crenulata Roxb.: a wild shrub of Himalayan hills | |
JPH1175793A (ja) | 飲料用ホウトウクウ組成物 | |
KR101768612B1 (ko) | 간기능 개선 효과를 갖는 식품용 조성물 및 이를 이용한 건강차의 제조방법 | |
KR101162581B1 (ko) | 기능성 곶감 및 그 제조방법 | |
Meuninck | Basic illustrated edible and medicinal mushrooms | |
KR20140041187A (ko) | 얼레지 추출물을 포함하는 항암 조성물 | |
Du Toit | Antioxidant content and potential of fresh and processed cladodes and fruit from different coloured cactus pear (Opuntia ficus-indica and Opuntia robusta) cultivars | |
KR20080087558A (ko) | 가래떡 및 그 제조방법 | |
KR101817053B1 (ko) | 더덕 추출물을 유효성분으로 포함하는 항산화, 항암, 항비만 또는 면역증진용 조성물 | |
Prinsloo et al. | Marula [Sclerocarya birrea (A. Rich) Hochst]: A review of traditional uses, phytochemistry, and pharmacology | |
KR101789246B1 (ko) | 쌀보리 신품종 '한백(익산117호)' 및 이를 포함하는 식품 조성물 | |
JP4269547B2 (ja) | 血糖降下剤及びその製造方法 | |
KR101285458B1 (ko) | 항암작용을 하는 건강보조식품 및 그 제조방법 | |
CN108378191A (zh) | 驼奶枸杞酥糖 | |
Oyeyemi et al. | Assessment of the nutritional potentials of Theobroma cacao L. and Coffee liberica W. Bull | |
KR100492941B1 (ko) | 생약재와 닭고기를 이용한 편의 당뇨식이용 밥의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121008 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131219 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141024 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151026 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161026 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171101 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20181018 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20191022 Year of fee payment: 15 |